Compare Edwards Lifesciences Corporation Common Stock (EW) vs iShares MSCI Australia ETF (EWA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs iShares MSCI Australia ETF — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while iShares MSCI Australia ETF trades at $28.27 (market cap $1.19B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 41.5× iShares MSCI Australia ETF's market cap, and Edwards Lifesciences Corporation Common Stock is more actively traded (3,508,027 versus 2,714,198). Which is the better fit depends on your goals.
| EW | EWA | |
|---|---|---|
Market Cap | $49.44B | $1.19B |
Volume | 3,508,027 | 2,714,198 |
Sector | Health | Broad Market / Factor |
52-Week High | $95.18 | $30.43 |
52-Week Low | $72.65 | $24.95 |
Enterprise Value | $45.90B | — |
Typical Hold Time | — | 63 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
The iShares MSCI Australia ETF (EWA) trades at $28.23, down 1.12% amid bearish technical signals and mixed institutional activity. Recent news highlights Australia's stock market hitting three-month lows due to inflation concerns from rising oil prices, though some analysts see upside potential given the country's commodity-driven economy. Technical indicators show selling pressure with moving averages signaling bearish momentum while oscillators remain neutral.
EWA faces near-term headwinds from Australian market volatility and inflation worries, but long-term prospects remain tied to global commodity demand. The ETF's commodity exposure provides diversification benefits, though investors should monitor Australian economic conditions and Federal Reserve policy impacts. Risk-reward appears balanced with technical resistance at $29 and support at $28.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About iShares MSCI Australia ETF
EWA tracks the MSCI Australia Index, providing broad exposure to large and mid-cap companies in the Australian equity market. It is structurally dominated by the financial and materials sectors, serving as a key instrument for investors seeking a single-country view of Australia's resource-rich and stable economy.
Read more on EWA →
